Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,319 | 26,362 | 29,349 | 29,128 | 31,201 |
| TOTAL | $21,502 | $26,667 | $29,960 | $29,661 | $31,291 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 0 | 1 | 1 |
| Investments And Advances | 0 | 0 | 0 | 0 | 10 |
| Intangibles | 10 | 12 | 14 | 15 | 17 |
| TOTAL | $10 | $12 | $14 | $16 | $28 |
| Total Assets | $21,512 | $26,679 | $29,974 | $29,677 | $31,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 929 | 775 | 922 | 906 | 838 |
| Accrued Expenses | 797 | 1,065 | 369 | 729 | 542 |
| TOTAL | $1,726 | $1,908 | $1,291 | $1,703 | $1,380 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,726 | $1,908 | $1,291 | $1,703 | $1,380 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,929 | 22,789 | 23,730 | 23,546 | 22,124 |
| Common Shares | 23 | 23 | 23 | 22 | 22 |
| Retained earnings | -135,083 | -128,930 | -123,999 | -118,925 | -114,890 |
| Other shareholders' equity | 7,508 | 7,461 | 7,403 | 7,346 | 7,289 |
| TOTAL | $19,786 | $24,771 | $28,683 | $27,974 | $29,939 |
| Total Liabilities And Equity | $21,512 | $26,679 | $29,974 | $29,677 | $31,319 |